• Editas Medicine, Mass Innovation Labs, Sinequa, And More: News From December 2016

    Bio-IT World News Brief | News, products, and partnerships from around the bio-IT community including news from Editas Medicine, Mass Innovation Labs, Sinequa, and more.

    Dec 19, 2016

  • Scientists Say the Clock of Aging May Be Reversible

    The New York Times | The technique, discovered by a team at the Salk Institute and tested in mice, cannot be applied directly to people, but it points toward better understanding of human aging.

    Dec 19, 2016

  • Modernas Mysterious Medicines

    Forbes | Backed by world-class science, a stealthy biotech has raised $1.9 billion by promising to change medicine forever. A new lawsuit opens a rare window into its secrets.

    Dec 15, 2016

  • Google’s Long Strange Life Span Trip

    MIT Technology Review | Why does a mole rat live 30 years but a mouse only three? With $1.5 billion in the bank, Google's anti-aging spinout Calico is rich enough to find out.

    Dec 15, 2016

  • Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease

    Xconomy | Chronic kidney disease affects more than 10 percent of U.S. adults, and the risk of developing the condition increases with age. New biotech Goldfinch Bio wants to turn genetic research into new therapies.

    Dec 14, 2016

  • New Funds for ONT, Self-Sequencing Challenge from Clive Brown

    Bio-IT World Oxford Nanopore Technologies yesterday announced $126 million in new funding through a private placement of ordinary shares. The investment round was led by new investor GT Healthcare, a pan-Asian fund with special reach in China, and existing investor Woodford Investment Management on behalf of its clients. Clive Brown, Oxford Nanopore's CTO, also released the "Cliveome" yesterday, his own self-sequenced genome.

    Dec 13, 2016

  • Complexities Of Consent

    Clinical Informatics News | As genomics continues to grow and evolve, the need to find a balance between scientific progress and patient protection is as great as ever.

    Dec 13, 2016

  • CRISPR Tech Heralds Hype, Hope, and Hurdles for Gene-Based Therapeutics

    Bio-IT World | The age of CRISPR has heralded in new lines of business based on cutting-edge, gene-editing technologies. Here are a few of the highlights of CRISPR's impact on the industry.

    Dec 12, 2016

  • First US Exascale Supercomputer Now On Track for 2021

    Top500 | The US Department of Energy's Exascale Computing Project (ECP) has changed its timeline for getting the first post-petascale system into the field. The new goal is to get an initial exascale system deployed sometime in 2021, with acceptance nine months after that. That shrinks the schedule significantly and puts the country back on a more competitive trajectory with regard to China and Japan.

    Dec 12, 2016

  • DNAnexus Reanalyzes Cancer Genome Atlas Data

    Bio-IT World Brief | DNAnexus announced today that it has performed uniform reanalysis and mutation calling on the world’s largest pan-cancer dataset, encompassing 10,487 patients across 33 cancer types from The Cancer Genome Atlas (TCGA). The mutation data has undergone additional quality control and filtering and is available as an open access dataset for download at the NCI Genomic Data Commons and on Synapse. The pipelines used are also fully available to researchers who wish to reproduce this TCGA mutation discovery via DNAnexus or a GitHub repository.

    Dec 9, 2016

  • Francis Collins says he would remain NIH director under Trump

    STAT | The director of the NIH said Friday that it would be a "privilege" to remain in that post if asked to stay by President-elect Donald Trump.

    Dec 9, 2016

  • Controversial Impact Factor Gets a Heavyweight Rival

    Nature News & Comment | On December 8, Elsevier launched the CiteScore Index, a new way to assess the quality of academic journals. Elsevier's CiteScore uses a larger database - and provides different results than the Journal Impact Factor.

    Dec 8, 2016

  • Biotech Trial of the Century Could Determine Who Owns CRISPR

    MIT Technology Review | Attorneys in a dispute over CRISPR gene-editing make their case to patent judges.

    Dec 7, 2016

  • Biotech Has A Solution For The Clean Water Crisis

    Forbes | As peak oil fears fade, water has emerged as the next resource crisis. The solution comes from drug development biotechnologies honed by the pharmaceutical industry.

    Dec 7, 2016

  • CRISPR Hearing Puts University of California on the Defensive

    STAT | The University of California has a steep hill to climb if it wants to overturn the 2014 decision awarding key CRISPR patents to the Broad Institute.

    Dec 7, 2016

  • AWS Wants To Dominate Beyond The Public Cloud With Lambda Updates

    Computerworld | Two years ago, Amazon Web Services made a splash when it introduced Lambda. Now, the company has gone even further to bring that technology outside of its core data center regions.

    Dec 6, 2016

  • At Late-Night ASH Talk Juno Execs Look Beyond Stalled Rocket Trial

    Xconomy | Juno Therapeutics is still mulling next steps for its lead product, an experimental cancer immunotherapy now stuck in limbo because five of 68 adult leukemia patients in its current study have died from severe brain swelling caused by the treatment.

    Dec 6, 2016

  • Groundbreaking Big Data Platform Can Improve The Quality Of Cancer Care

    Bio-IT World Contributed Commentary | CancerLinQ helps to gain insights from the 97% of cancer patients not involved in clinical trials to help deliver better, more data-driven decision-making.  

    Dec 5, 2016

  • Eurofins Genomics Creates Streamlined DNA Synthesizer

    Louisville Business First | Eurofins Genomics recently moved its headquarters to Louisville. Here's what they've been up to since.

    Dec 2, 2016

  • TGen Joins City of Hope System

    Bio-IT World News Brief  Translational Genomics Research Institute—TGen—has formed an alliance with City of Hope, a world-renowned independent research and cancer and diabetes treatment center, to make precision medicine a reality for patients. City of Hope hopes to provide a significant clinical setting to advance scientific discoveries made by TGen.

    Dec 2, 2016